Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates of restenosis without increasing the risk of stent thrombosis. We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Lancet |
Vol/bind | 375 |
Udgave nummer | 9720 |
Sider (fra-til) | 1090-9 |
Antal sider | 10 |
ISSN | 0140-6736 |
DOI | |
Status | Udgivet - 27 mar. 2010 |
ID: 34077476